Advertisement

Topics

Seattle Genetics, Inc. Company Profile

02:53 EST 18th February 2019 | BioPortfolio

Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company's lead product candidate, brentuximab vedotin (SGN-35), is in a pivotal trial under a Special Protocol Assessment with the U.S. Food and Drug Administration. Brentuximab vedotin is being developed in collaboration with Millennium: The Takeda Oncology Company. In addition, Seattle Genetics has five other clinical-stage programs: lintuzumab (SGN-33), dacetuzumab (SGN-40), SGN-70, SGN-75 and ASG-5ME. Seattle Genetics has collaborations for its ADC technology with multiple biotechnology and pharmaceutical companies, including Bayer, Celldex Therapeutics, Daiichi Sankyo, Genentech, GlaxoSmithKline, MedImmune, a subsidiary of AstraZeneca, Millennium: The Takeda Oncology Company and Progenics, as well as an ADC co-development agreement with Agensys, an affiliate of Astellas. More information can be found at http://www.seattlegenetics.com.


News Articles [606 Associated News Articles listed on BioPortfolio]

Seattle Genetics' Adcetris Has Potential to Change Treatment for T-Cell Lymphoma

Seattle Genetics and its development partner Takeda recently announced stellar Phase III data from its ECHELON-2 clinical trial of Adcetris for peripheral T-cell lymphoma. Clay Siegall, president and ...

Seattle Genetics Announces Adcetris Approval in Japan for Frontline Hodgkin Lymphoma

NewsSeattle Genetics and Takeda are jointly developing Adcetris.

Seattle Genetics doses first patient in Phase I trial of SEA-BCMA

Seattle Genetics has dosed the first patient in a Phase I clinical trial to examine the safety and tolerability of...Read More... The post Seattle Genetics doses first patient in Phase I trial of SEA-...

Seattle Genetics To Receive $30 Mln Milestone Payment From Takeda

WASHINGTON (dpa-AFX) - Seattle Genetics, Inc. (SGEN) announced that its collaborator, Takeda Pharmaceutical Company Limited, received approval from the European Commission to extend the marketing ...

Seattle Genetics begins blood cancer trial with SEA-BCMA

SEA-BCMA is an investigational antibody empowered using Seattle Genetics’ proprietary Sugar Engineered Antibody (SEA) technology designed to enhance antibody dependent cellular cytotoxicity. The tar...

Seattle Genetics and Takeda report positive data from ECHELON-2 trial

Seattle Genetics and Takeda have reported positive topline results from the Phase II ECHELON-2 trial investigating adcetris (brentuximab vedotin) as...Read More... The post Seattle Genetics and Takeda...

Seattle Genetics' lymphoma drug gains European Commission's approval

The European Commission has approved Seattle Genetics' Adcetris, or brentuximab vedotin, in combination with AVD, or adriamyc -More- 

US FDA approves Seattle Genetics' Adcetris in combo with CHP chemotherapy for previously untreated sALCL/other CD30─expressing PTCL

Seattle Genetics, Inc announced a new approval for Adcetris (brentuximab vedotin) in combination with CHP chemotherapy (cyclophosphamide, doxorubicin, prednisone) from the US Food and Drug Administrat...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [seattle children's hospital]

Oxygen

Adcetris [seattle genetics, inc.]

These highlights do not include all the information needed to use ADCETRIS safely and effectively.  See full prescribing information for ADCETRIS. ADCETRIS (brentuximab vedotin) for injection, for in...

Ixinity [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use IXINITY® safely and effectively. See full prescribing information for IXINITY.. IXINITY [coagulation factor IX (recombinant)] Lyophil...

PubMed Articles [591 Associated PubMed Articles listed on BioPortfolio]

Measles and Rubella Seroprevalence in Mother-Infant Pairs in Rural Nepal and the United States: Pre- and Post-Elimination Populations.

We sought to compare seroprevalence of protective measles and rubella-specific antibody in mother-infant pairs across two populations: a pre-disease elimination Nepal population with recently introduc...

Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle.

To describe the "continuum of care" for hepatitis C virus (HCV) and related health service utilization among persons who inject drugs (PWID) in the Seattle metropolitan area.

Sleepmore in Seattle: Later school start times are associated with more sleep and better performance in high school students.

Most teenagers are chronically sleep deprived. One strategy proposed to lengthen adolescent sleep is to delay secondary school start times. This would allow students to wake up later without shifting ...

Genetics is the logic of life (at least of mine).

I retrace my path from math to medicine to biochemistry to yeast genetics, my focus on infectious diseases of yeast and finally prions. My discovery of yeast prions relied on my particular focus on th...

Prohibiting Genetic Discrimination to Promote Science, Health, and Fairness.

Protections against genetic discrimination advance genetics research and the clinical use of genetics, as well as ensure the ethical use of genetic data. Ten years after the passage of the Genetic Inf...

Clinical Trials [388 Associated Clinical Trials listed on BioPortfolio]

Impact of Non-Commercialism Policy in Seattle Schools

This pilot study on the impact of a non-commercialism policy in Seattle schools will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on a...

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Impact of Non-Commercialism Policy in Seattle Schools

This is a 3-year pilot study funded by National Institute of Health will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on and adopted b...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

Companies [257 Associated Companies listed on BioPortfolio]

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

Seattle Genetics

Seattle Genetics, Inc. is a biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Our strategy is focused on advancing our portfolio...

Population Genetics

Harnessing The Power of Populations™ Population Genetics’ approach takes the process of genetic analysis one step further. It enables the elaboration and testing of distinct hypotheses...

More Information about "Seattle Genetics, Inc." on BioPortfolio

We have published hundreds of Seattle Genetics, Inc. news stories on BioPortfolio along with dozens of Seattle Genetics, Inc. Clinical Trials and PubMed Articles about Seattle Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Seattle Genetics, Inc. Companies in our database. You can also find out about relevant Seattle Genetics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...


Corporate Database Quicklinks



Searches Linking to this Company Record